| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |